• Home
  • NEW DAY MEDICINE
  • 12(50)2022
  • 13 -12 (50) 2022 — Teshaev U.Sh., Yarbekov R.R. — MINIMALLY INVASIVE CARDIAC SURGERY / CORONARY ARTERY BYPASS GRAFTING DEPENDING ON PRESENCE / ABSENCE OF OBESITY

13 -12 (50) 2022 — Teshaev U.Sh., Yarbekov R.R. — MINIMALLY INVASIVE CARDIAC SURGERY / CORONARY ARTERY BYPASS GRAFTING DEPENDING ON PRESENCE / ABSENCE OF OBESITY

MINIMALLY INVASIVE CARDIAC SURGERY / CORONARY ARTERY BYPASS GRAFTING DEPENDING ON PRESENCE / ABSENCE OF OBESITY

Teshaev U.Sh. Bukhara State Medical Institute;

Yarbekov R.R. Republican Specialized Scientific and Practical Medical Center for Surgery named after Academician V.V. Vakhidov.

Murodov M.M. Republican Specialized Scientific and Practical Medical Center for Surgery named after Academician V.V. Vakhidov.

Nishonov N.A. Republican Specialized Scientific and Practical Medical Center for Surgery named after Academician V.V. Vakhidov.

Axmedov X.E. Republican Specialized Scientific and Practical Medical Center for Surgery named after Academician V.V. Vakhidov.

Tursunov Sh.L. Bukhara State Medical Institute;

Resume

Minimally invasive myocardial revascularization (MIMR) is focused on performing multiple coronary bypass grafting (CABG) through the left anterolateral mini-thoracotomy, one of the subtypes of which is MICSCAB (Minimally Invasive Cardiac Surgery/Coronary Artery Bypass Grafting).

Objective: To evaluate the effectiveness and safety of CABG using the MICSCAB method in patients with coronary artery disease with multivessel coronary disease in a comparative aspect, depending on the presence / absence of obesity.

Material and methods: 41 patients with coronary artery disease and multivessel coronary disease were examined. Mean age of patients = 62.8±6.7 years. All persons were male. All patients underwent general clinical laboratory and functional studies, as well as coronary angiography (CAG) and CABG-MICSCAB surgery. The presence or absence of obesity was determined by calculating the body mass index (BMI, kg/m2).

Results: Patients with obesity in terms of general clinical parameters were characterized by younger age, more frequent occurrence of tachycardia, but relatively intact central hemodynamic parameters, despite more complex lesions of the coronary vessels.

Patients with obesity, despite the good immediate prognosis of CABG-MICSCAB, were characterized by a greater volume of total blood loss and more frequent postoperative use of donor blood components, as well as relatively worse flowmetry data (all p > 0.05).

In patients with coronary artery disease with obesity, CABG-MICSCAB intervention can be considered as the operation of choice, due to its low trauma and good immediate prognosis.

Conclusion: The results of MICSCAB technique are not inferior to those using the traditional CABG technique, and in some respects even surpass it. Our results also contribute to a positive conclusion on the use of this technique, including in patients with an increased level of BMI (i.e., with obesity of 1-2 degrees).

Key words: coronary artery bypass grafting (CABG); Minimally Invasive Cardiac Surgery/Coronary Artery Bypass Grafting (MICSCAB); body mass index (BMI); obesity.

First page

68

Last page

81

For citation: Teshaev U.Sh., Yarbekov R.R., Murodov M.M. Nishonov N.A., Axmedov X.E. Tursunov Sh.L. MINIMALLY INVASIVE CARDIAC SURGERY / CORONARY ARTERY BYPASS GRAFTING DEPENDING ON PRESENCE / ABSENCE OF OBESITY //New Day in Medicine 12(50)2022 68-81 https://clck.ru/336DPY

LIST OF REFERENCES:

  1. Combest S., Hantler C.B. Coronary artery bypass grafting (CABG). In: Bready L.L., Dillman D., Noorily S.H., editors. Decision making in anesthesiology. 4th ed. Philadelphia:Mosby, Inc.; 2007. p. 282-285.
  2. McGinn JTJr, et al. Minimally invasive coronary artery bypass grafting: Dual center experience in 450 consecutive patients. Circulation. 2009.
  3. Зеньков А.А. Непосредственные и отдаленные результаты многососудистого миниинвазивного коронарного шунтирования без затрагивания аорты: исследование с уравненными группами пациентов. //Клиническая и экспериментальная хирургия. Журнал им. акад. Б.В. Петровского. 2018;6(1):10-20.
  4. Hannan E, Wu C, Smith CR, Higgins RS, Carlson RE, Culliford AT. Off-pump versus on-pump coronary artery bypass graft surgery: differences in short-term outcomes and in long-term mortality and need for subsequent revascularization. Circulation. 2007;116:1145-1152.
  5. Kobayashi J., Tashiro T., Ochi M. et al. Early outcome of a randomized comparison of off-pump and on-pump multiple arterial coronary revascularization. Circulation. 2005;112:I338-1143.
  6. Lemma M.G., Coscioni E., Tritto F.P. et al. On-pump versus offpump coronary artery bypass surgery in high-risk patients: operative results of a prospective randomized trial (on-off study). //J Thorac Cardiovasc Surg. 2012;143:625-631.
  7. McGinn J.T., Shariff M.A., Nabagiez J.P. et al. Minimally Invasive CABG is Safe and Reproducible: Report on the First Thousand Cases. Presentation at International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS). Boston. 2014.
  8. Nambiar P., Kailash S. Coronary artery bypass grafting – is it time to do away with sternotomy? 15 ISMICS Annual Scientific Meeting.Berlin. 2015 3-6 June
  9. Исаев М.Н., Екимов С.С., Чернов И.И., и др. Бимаммарное коронарное шунтирование на работающем сердце через левостороннюю мини-торакотомию. Клиническая и экспериментальная хирургия. //Журнал им. акад. Б.В. Петровского. 2016;6(4):27-30.
  10. Киладзе И.З., Жбанов И.В., Урюжников В.В. и др. Миниинвазивное множественное коронарное шунтирование через левую миниторакотомию. XXIII Ежегодная Сессия НМИЦ ССХ им. А.Н. Бакулева. М. 2019, 19-21 мая.
  11. Юрченко Д.Л., Пайвин А.А., Денисюк Д.О., и др. Многососудистое минимально инвазивное шунтирование коронарных артерий. //Грудная и сердечно-сосудистая хирургия. 2015;(6):40-46.
  12. Teo K.K., Cohen E., Buller C. et al. Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology/ Canadian Society of Cardiac Surgery position statement on revascularization-multivessel coronary artery disease. //Can J Cardiol 2014; 30: 1482–1491.
  13. Neumann F., Sousa-Uva M., Ahlsson A. ESC/EACTS guidelines on myocardial revascularization. //EuroIntervention 2019; 40: 87–165.
  14. Fihn S.D., Gardin J.M., Abrams J. et al. 2012 ACCF/AHA/ACP/ AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: Executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 2012; 126: 3097–3137.
  15. Mohr F.W., Morice M.C., Kappetein A.P. et al. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial. Lancet 2013; 381: 629–638.
  16. Farkouh M.E., Domanski M., Dangas G.D. et al. Long-term survival following multivessel revascularization in patients with diabetes: the FREEDOM Follow-On Study. //J Am Coll Cardiol 2019; 73: 629–638.
  17. Giustino G., Serruys P.W., Sabik J.F. et al. Mortality after repeat revascularization following PCI or CABG for left main disease: the EXCEL trial. JACC Cardiovasc Interv 2020; 13: 375–387.
  18. Mäkikallio T., Holm N.R., Lindsay M. et al. Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial. Lancet 2016; 388: 2743–2752.
  19. Ruel M., Falk V., Farkouh M.E. et al. Myocardial revascularization trials. //Circulation 2018; 138: 2943–2951.
  20. Ruel M. Editorial: coronary artery surgery: a resurgence and new opportunity to serve our patients better. Curr Opin Cardiol 2019; 34: 627.

file

download